Ozempic maker defends high U.S. price: It's 'helping' reduce the cost of obesity
nbcnews.com
nbcnews.com
Metformin is a small, simple molecule that has long fallen out of patent, and is available very cheaply.
https://en.wikipedia.org/wiki/Lac-Phe
https://med.stanford.edu/news/all-news/2024/03/metformin-wei...
Also, it's far less effective than GLP1 RAs at weight loss, which is what most people want.
OK, the Iraq war cost half that. Lets invade Denmark to beat obesity.
It won't be up to Novo Nordisk to reduce the cost of GLP1 RAs -- it will be up to other entrants into the market (that said, there are worryingly few), and huge companies taking up manufacturing of GLP1s and similar compounds.
At this point, companies partnering with compounding pharmacies might hit mainstream (more than it already has) and be the go-to way to get GLP1 RAs.
There's already a Liraglutide (Victoza/Saxenda) generic:
https://glp1.guide/content/victoza-generic-hits-the-market
Though I've seen some anecdotal reports that the generic was worse than regular Victoza.